Log in

ProShares UltraShort Nasdaq Biotechnology Stock Forecast, Price & News

+0.54 (+1.79 %)
(As of 10/26/2020 04:30 PM ET)
Today's Range
Now: $30.67
50-Day Range
MA: $31.06
52-Week Range
Now: $30.67
Volume25,964 shs
Average Volume59,134 shs
Market Capitalization$13.68 million
P/E RatioN/A
Dividend Yield0.22%

Geographic Exposure of BIS

Currency Exposure of BIS

Sector Exposure of BIS

Basic Details

Issuer ProShares
Fund NameProShares UltraShort Nasdaq Biotechnology
Tax ClassificationRegulated Investment Company
Inception Date4/6/2010
Fund ManagerMichael Neches, Tarak Dave

Fund Focus

Asset ClassEquity
BenchmarkNasdaq Biotech Index
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$11.18 million
Average Daily Volume$54,811.20

ETF Expenses

Management Fee0.75%
Other Expenses0.36%
Total Expenses1.11%
Fee Waiver-0.16%
Net Expenses0.95%

Administrator, Advisor and Custodian

AdministratorJ.P. Morgan Investor Services Co.
AdvisorProShare Advisors LLC
CustodianJPMorgan Chase Bank, N.A.
DistributorSEI Investments Distribution Co.
Transfer AgentJPMorgan Chase Bank, N.A.
Lead Market MakerVirtu Financial
+0.54 (+1.79 %)
(As of 10/26/2020 04:30 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BIS News and Ratings via Email

Sign-up to receive the latest news and ratings for BIS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

ProShares UltraShort Nasdaq Biotechnology (NYSEARCA:BIS) Frequently Asked Questions

How has ProShares UltraShort Nasdaq Biotechnology's stock been impacted by COVID-19 (Coronavirus)?

ProShares UltraShort Nasdaq Biotechnology's stock was trading at $16.13 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BIS shares have increased by 90.1% and is now trading at $30.67.
View which stocks have been most impacted by COVID-19

What other stocks do shareholders of ProShares UltraShort Nasdaq Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ProShares UltraShort Nasdaq Biotechnology investors own include Galapagos (GLPG), VanEck Vectors Biotech ETF (BBH), Virtus LifeSci Biotech Clinical Trials ETF (BBC), The Boeing (BA), EKIMAS (ASNB), ARK Genomic Revolution Multi-Sector ETF (ARKG), Aphria (APHQF), Aphria (APHA), Acasti Pharma (ACST) and Aclaris Therapeutics (ACRS).

What is ProShares UltraShort Nasdaq Biotechnology's stock symbol?

ProShares UltraShort Nasdaq Biotechnology trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "BIS."

How do I buy shares of ProShares UltraShort Nasdaq Biotechnology?

Shares of BIS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ProShares UltraShort Nasdaq Biotechnology's stock price today?

One share of BIS stock can currently be purchased for approximately $30.67.

How big of a company is ProShares UltraShort Nasdaq Biotechnology?

ProShares UltraShort Nasdaq Biotechnology has a market capitalization of $13.68 million.

This page was last updated on 10/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.